dc.creatorGallivanone, Francesca
dc.creatorValente, Mauro Andres
dc.creatorSavi, Annarita
dc.creatorCanevari, Carla
dc.creatorCastiglioni, Isabella
dc.date.accessioned2018-11-06T19:39:11Z
dc.date.accessioned2022-10-15T15:09:34Z
dc.date.available2018-11-06T19:39:11Z
dc.date.available2022-10-15T15:09:34Z
dc.date.created2018-11-06T19:39:11Z
dc.date.issued2017-06-01
dc.identifierGallivanone, Francesca; Valente, Mauro Andres; Savi, Annarita; Canevari, Carla; Castiglioni, Isabella; Targeted radionuclide therapy: frontiers in theranostics; Landmark; Frontiers in bioscience (Landmark edition); 22; 1-6-2017; 1750-1759
dc.identifier1093-4715
dc.identifierhttp://hdl.handle.net/11336/63817
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4400864
dc.description.abstractThe concept of targeted radionuclide therapy (TRT) relies on the use of injected nuclear medicine as treating agents, targeted at the cellular or molecular level. The growth of the interest in TRT was stimulated by the advances in radionuclide production and labeling as well as by the improvement in the knowledge of appropriate and specific molecular targets. In recent years, different studies on TRT were focused on the evaluation of radionuclide compounds able to combine imaging of the disease with TRT, in a theranostic approach. This approach is of particular interest towards the personalization of treatments, allowing both the baseline characterization of oncological pathologies and treatment optimization by correct dosimetric calculation as well as therapy monitoring. This paper presents a review of recent literature on TRT, with a particular focus on clinical applications promoting such a theranostic approach, showing the impact of the synergy of diagnostic imaging and therapeutics.
dc.languageeng
dc.publisherLandmark
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/https://dx.doi.org/10.2741/4569
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.bioscience.org/2017/v22/af/4569/list.htm
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectRadionuclide therapy
dc.subjectCancer
dc.subjectImaging
dc.subjectReview
dc.titleTargeted radionuclide therapy: frontiers in theranostics
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución